Related references
Note: Only part of the references are listed.Glycan profiles of the 27 N-glycosylation sites of the HIV envelope protein CN54gp140
Martin Pabst et al.
BIOLOGICAL CHEMISTRY (2012)
High-Mannose Glycan-Dependent Epitopes Are Frequently Targeted in Broad Neutralizing Antibody Responses during Human Immunodeficiency Virus Type 1 Infection
Christy L. Lavine et al.
JOURNAL OF VIROLOGY (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic
Zelda Euler et al.
JOURNAL OF VIROLOGY (2011)
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2011)
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
Elin S. Gray et al.
JOURNAL OF VIROLOGY (2011)
Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2011)
Characterization of Glycosylation Profiles of HIV-1 Transmitted/Founder Envelopes by Mass Spectrometry
Eden P. Go et al.
JOURNAL OF VIROLOGY (2011)
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan et al.
NATURE (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade
Camille Bonomelli et al.
PLOS ONE (2011)
Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses
Hugo Mouquet et al.
PLOS ONE (2011)
Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque
Laura M. Walker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Xueling Wu et al.
SCIENCE (2011)
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Ron Diskin et al.
SCIENCE (2011)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Robert Pejchal et al.
SCIENCE (2011)
The Role of Antibodies in HIV Vaccines
John R. Mascola et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Structural Analysis of a Highly Glycosylated and Unliganded gp120-Based Antigen Using Mass Spectrometry
Liwen Wang et al.
BIOCHEMISTRY (2010)
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
Michael S. Seaman et al.
JOURNAL OF VIROLOGY (2010)
Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L
Ann J. Hessell et al.
JOURNAL OF VIROLOGY (2010)
Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody Neutralization
James M. Binley et al.
JOURNAL OF VIROLOGY (2010)
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Hugo Mouquet et al.
NATURE (2010)
Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
Cherie T. Ng et al.
NATURE MEDICINE (2010)
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level
Evelien M. Bunnik et al.
NATURE MEDICINE (2010)
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
Davide Corti et al.
PLOS ONE (2010)
Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
Catarina E. Hioe et al.
PLOS ONE (2010)
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
Katie J. Doores et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Tongqing Zhou et al.
SCIENCE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
Laura M. Walker et al.
PLOS PATHOGENS (2010)
Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
Susan Zolla-Pazner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins
Eden P. Go et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Frequency and Phenotype of Human Immunodeficiency Virus Envelope-Specific B Cells from Patients with Broadly Cross-Neutralizing Antibodies
Nicole A. Doria-Rose et al.
JOURNAL OF VIROLOGY (2009)
Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2009)
Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors
Elin S. Gray et al.
JOURNAL OF VIROLOGY (2009)
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
Melissa D. Simek et al.
JOURNAL OF VIROLOGY (2009)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid et al.
NATURE (2009)
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
Ann J. Hessell et al.
NATURE MEDICINE (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?
David C. Montefiori et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site
Barna Dey et al.
PLOS PATHOGENS (2009)
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Ann J. Hessell et al.
PLOS PATHOGENS (2009)
Correlates of vaccine-induced immunity
Stanley A. Plotkin
CLINICAL INFECTIOUS DISEASES (2008)
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
Thomas Tiller et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility
Eden P. Go et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
James M. Binley et al.
JOURNAL OF VIROLOGY (2008)
Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection
Evelien M. Bunnik et al.
JOURNAL OF VIROLOGY (2008)
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Gunilla B. Karlsson Hedestam et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Dissecting the neutralizing antibody-specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
Amandeep K. Dhillon et al.
JOURNAL OF VIROLOGY (2007)
Ligands for the β-glucan receptor, Dectin-1, assigned using designer microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides
AS Palma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Dissection of the carbohydrate specificity of the broadly neutralizing-anti-HIV-1 antibody 2G12
DA Calarese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
A Trkola et al.
NATURE MEDICINE (2005)
Identifying epitopes of HIV-1 that induce protective antibodies
S Zolla-Pazner
NATURE REVIEWS IMMUNOLOGY (2004)
Characterization of glycopeptides from HIV-ISF2 gp120 by liquid chromatography mass spectrometry
JM Cutalo et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2004)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
DA Calarese et al.
SCIENCE (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
RS Veazey et al.
NATURE MEDICINE (2003)
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades
MK Gorny et al.
JOURNAL OF VIROLOGY (2002)
The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120
RW Sanders et al.
JOURNAL OF VIROLOGY (2002)
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120
CN Scanlan et al.
JOURNAL OF VIROLOGY (2002)
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
PWHI Parren et al.
JOURNAL OF VIROLOGY (2001)
Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer
RW Walters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells
XG Zhu et al.
BIOCHEMISTRY (2000)
Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins
XZ Yang et al.
JOURNAL OF VIROLOGY (2000)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
TW Baba et al.
NATURE MEDICINE (2000)
Share Paper
